Fritextsökning
Innehållstyper
-
Bioarctic får USA-patent får antikropp mot Parkinsons sjukdom
Den svenska läkemedelsutvecklaren Bioarctic har beviljats substanspatent i USA för en antikropp som utvecklats mot Parkinsons sjukdom.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Torgny Fornstedt: Analytisk kemi måste hitta tillbaka till sina rötter
Det behövs fler kunniga analytiska kemister både på universiteten och inom industrin, skriver Torgny Fornstedt i en krönika.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
IT snabbar på läkemedels-utvecklingen
Efter en trevande start ökar användningen av digitala hjälpmedel för att hitta och behålla försökspersoner i kliniska prövningar. De möjliga tidsvinsterna är hi...
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Läkemedelsutveckling i mobilen
Mobilspel ska snabba på utvecklingen av nya behandlingar mot cancer.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Life science blir "death science" i nya Bond
I den senaste Bondfilmen, "No time to die", har filmskaparna tagit steget in i biologi och genforskning. Life science har aldrig varit dödligare...
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Trenden som påverkar life science i grunden
Morgondagens samhälle ställer nya krav på life science-branschen. Med ökad patientmakt och nya tekniska lösningar ökar kraven på nya samarbeten och affärsmodeller.
BREAKING